Copertina

Determining a Stability Prognostic Panel for 636 Patients With Melanoma Using a Machine Learning Computational Framework

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Hewen Guan, Yuankuan Jiang, Yuying Cui, Shumeng Zhang, Yuxin Chen, Yanghong Li, Feng Han, Qihang Yuan, Jingrong Lin
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Survival Prognostic Factors in Patients With Melanoma and Unidentifiable Sentinel Lymph Node: A Case Series of 72 Patients
di: Irina Ciobotariu, et al.
Pubblicazione: (2025)

Prognostic Biomarkers for Anti‐ PD ‐1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma
di: Marek Pásek, et al.
Pubblicazione: (2025)

Segmental vitiligo: autoimmune pathogenesis, neuronal mechanisms, and somatic mosaicism
di: Xiran Lin, et al.
Pubblicazione: (2024)

Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual‐Tumour Mouse Melanoma Model
di: Marine Delmas, et al.
Pubblicazione: (2025)

Melanoma/Oncology
Pubblicazione: (2024)

Melanoma/Oncology
Pubblicazione: (2025)

C‐Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV ‐Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single‐Center, Retrospective Cohort Study
di: Ken Horisaki, et al.
Pubblicazione: (2025)

Staphylococcus Enrichment in Cutaneous Melanoma
di: Hyoung Soo Park, et al.
Pubblicazione: (2025)

Matrix Metalloproteinase Inhibition in Melanoma
di: Ellie Zhang, et al.
Pubblicazione: (2026)

Impact of Surgical Delay on Prognosis in Patients With Cutaneous Melanoma: A Single‐Institution Retrospective Study in Japan
di: Kazutoshi Nishimura, et al.
Pubblicazione: (2025)

Line‐Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) of Amelanotic Melanoma in a Patient With Oculocutaneous Albinism
di: Gerardo Palmisano, et al.
Pubblicazione: (2025)

Morphological and Prognostic Values of Skin Lesions in Patients with COVID‐19
di: Mahmoud A. Rageh, et al.
Pubblicazione: (2024)

Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma
di: Dong‐Dong Jia, et al.
Pubblicazione: (2025)

Analysis of Medical Costs of Melanoma Using a Japanese National Database
di: Meiko Goto, et al.
Pubblicazione: (2026)

Reply to: Melanoma of the penis: the importance of a multidisciplinary approach
di: Christopher B. Bunker, et al.
Pubblicazione: (2024)

Correction to “The Dynamics of Circulating Tumour DNA ( ctDNA ) During Treatment Reflects Tumour Response in Advanced Melanoma Patients”
Pubblicazione: (2025)

A Case of Pediatric Spitz Melanoma With a ZEB2 :: ALK Fusion
di: Nathanael C. Jensen, et al.
Pubblicazione: (2026)

Neutrophil‐to‐Lymphocyte Ratio Associated With Worse Melanoma Specific‐Survival and Distant Metastasis Free Survival in Localized (Stage I and II ) Cutaneous Melanoma: An Observational Retrospective Study on 988 Patients
di: Irina Ciobotariu, et al.
Pubblicazione: (2025)

Clinical Outcomes of Dacarbazine After Failure of Immune Checkpoint Inhibitors: A Case Study of 15 Japanese Patients With Malignant Melanoma
di: Ken Horisaki, et al.
Pubblicazione: (2026)

Improving Melanoma Risk Stratification of Skin Color Type by Polygenic Scores of Skin Color and Melanoma
di: Huy Tran, et al.
Pubblicazione: (2025)

Exophytic Shoulder Mass as Initial Presentation of a Neglected Melanoma
di: Pablo Balado‐Simó, et al.
Pubblicazione: (2026)

Real‐World Efficacy and Safety of MEK Inhibitor for Patients With Advanced NRAS ‐Mutant Melanoma: A Single‐Center Retrospective Study in Japan
di: Eiji Nakano, et al.
Pubblicazione: (2025)

Adjuvant Therapy Using Dabrafenib plus Trametinib in Chinese Patients with Resected Stage III Melanoma: A Multicenter Retrospective Cohort Study
di: Dong-Dong Jia, et al.
Pubblicazione: (2024)

Dynamic Optical Coherence Tomography Enhances Melanoma Detection
di: Carmen Cantisani, et al.
Pubblicazione: (2025)

Melanoma and menarche: Exploring the hormonal impact in pediatric cases
di: Elisabetta Magnaterra, et al.
Pubblicazione: (2024)

Melanoma and cannabinoids: A possible chance for cancer treatment
di: Mariarosaria Galeano, et al.
Pubblicazione: (2024)

Advanced Verrucous Malignant Melanoma Arising on the Plantar Arch
di: Yuto Yamamura, et al.
Pubblicazione: (2025)

The Melanoma Pathology Report: What to Expect and How to Interpret It
di: Alexander Nirenberg, et al.
Pubblicazione: (2025)

A Clinical Perspective on Melanoma Overdiagnosis
di: Jennifer Sheerin, et al.
Pubblicazione: (2025)

The Role of ROS ‐Mediated Mitochondrial Dysfunction in the Development of Malignant Melanoma
di: Lei Li, et al.
Pubblicazione: (2025)

Needle before Scalpel: Considering the Role of Intratumoral Therapy in Melanoma
di: Theodore Henry Katz, et al.
Pubblicazione: (2024)

Use of Baricitinib in Patients With TIF1 ‐γ Positive Dermatomyositis Following a COVID ‐19 Infection
di: Guan‐Kai Lai, et al.
Pubblicazione: (2026)

Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025
di: Satoshi Fukushima, et al.
Pubblicazione: (2025)

Gender Disparities in Melanoma: Advances in Diagnosis, Treatment, and the Role of Artificial Intelligence
di: Diala Ra'Ed Kamal Kakish, et al.
Pubblicazione: (2025)

Extended‐Interval Dosing of an Immune Checkpoint Inhibitor Following a Complete Response in Melanoma: A Case Report
di: Yoshiyuki Matsui, et al.
Pubblicazione: (2025)

Serum Nectin‐4 as a Potential Prognostic Biomarker for Extramammary Paget Disease
di: Hiromichi Morita, et al.
Pubblicazione: (2025)

Psychological Wellbeing After a Diagnosis of Melanoma In Situ: A Qualitative Interview Study
di: Lejie Zheng, et al.
Pubblicazione: (2026)

Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous Melanoma
di: Corinne I. Stoffel, et al.
Pubblicazione: (2025)

CD 24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target
di: Claudia Lasalle, et al.
Pubblicazione: (2026)

MCAM Expression Facilitates Melanoma–Endothelial Interactions and Promotes Metastatic Disease Progression
di: Andreas Dominik Braun, et al.
Pubblicazione: (2025)